Archives20242023202220212020201920182017201620152014201320122011 June 30, 2017Annual General Meeting and Investor Presentation Read More June 07, 2017Notice of Annual General Meeting on 30 June 2017 at 10.30am Read More June 06, 2017Final Results Announcement for the twelve months ended 31 December 2016 Read More May 24, 2017Notification of full year results – 1st June 2017 Read More May 18, 2017Update on Lupuzor™ Pivotal Phase III Study Read More March 21, 2017Notification of Major Interest by Legal & General Read More March 10, 2017Successful £4.1 Million Fund Raise Following the Close of the Accelerated Bookbuild Read More March 10, 2017Accelerated Bookbuild for the Issue of Equity Read More January 25, 2017Update on Lupuzor™ Pivotal Phase III Study – Full Analysis of Patient Recruitment Read More January 24, 2017Change of Adviser Read More December 22, 2016Update on Lupuzor™ Pivotal Phase III Study – Patient Recruitment Completed Read More November 16, 2016Update on Cancer Compound IPP-204106 ‘Nucant’ Read More 1…1314151617…21
March 10, 2017Successful £4.1 Million Fund Raise Following the Close of the Accelerated Bookbuild Read More
January 25, 2017Update on Lupuzor™ Pivotal Phase III Study – Full Analysis of Patient Recruitment Read More
December 22, 2016Update on Lupuzor™ Pivotal Phase III Study – Patient Recruitment Completed Read More